Background & Aims: Post-thoracotomy pain in pediatric patients is challenging to manage, affecting postoperative recovery, ventilation, and opioid consumption. Caudal Epidural (CE) has been a traditional approach, but Serratus Anterior Plane Block (SAPB) has gained attention as a viable alternative. This study compares the efficacy, opioid requirements, and safety of SAPB vs. CE in pediatric thoracotomy patients. Methods: This randomized controlled trial was conducted at a tertiary care hospital on 32 pediatric patients (6 months–7 years) undergoing thoracotomy. Patients were randomized into: SAPB Group (n=16): Ultrasound-guided SAPB using 0.125% Bupivacaine (0.4 ml/kg) + Dexmedetomidine (2 μg/kg), CE Group (n=16): Caudal Epidural using 0.125% Bupivacaine (1.25 ml/kg) + Dexmedetomidine (2 μg/kg). Primary Objectives: Total fentanyl consumption (24 hours), Time to first rescue analgesia. Secondary Objectives: Intraoperative fentanyl requirement, FLACC pain scores, Hemodynamic stability & complications Results: SAPB significantly reduced fentanyl consumption (1.81±0.48 µg/kg) compared to CE (3.38±0.70 µg/kg, p=0.001). Time to first rescue analgesia was prolonged in SAPB (237.88±62.68 min) vs. CE (126.69±20.65 min, p=0.001). No major complications were reported in either group. Conclusion: SAPB is a safe and effective alternative to CE for post-thoracotomy pain in pediatric patients, providing longer-lasting analgesia and reduced opioid consumption.
Post-thoracotomy pain is among the most severe types of postoperative pain, particularly in pediatric patients, as it can lead to respiratory distress, prolonged ventilation, and delayed recovery【1】. Effective pain management is essential to reduce opioid consumption, prevent pulmonary complications, and enhance recovery【2】. Despite advances in anesthesia, post-thoracotomy pain remains undertreated, contributing to chronic pain syndromes and prolonged hospital stays【3】. Caudal epidural (CE) analgesia has been widely used in pediatric anesthesia for thoracic and abdominal surgeries, providing reliable pain relief in the early postoperative period【4】. However, CE has several limitations, including variable analgesic spread, shorter duration of action, potential hemodynamic instability, and contraindications in coagulopathic patients【5,6】. Moreover, the risk of urinary retention and motor blockade can be concerning, particularly in younger children【7】.
In recent years, Serratus Anterior Plane Block (SAPB) has gained attention as an effective regional analgesic technique for thoracic surgeries【8】. SAPB, first described by Blanco et al. (2013), targets the lateral cutaneous branches of intercostal nerves (T2–T9), providing unilateral thoracic analgesia without affecting sympathetic nerve fibers【9】. Compared to CE, SAPB is associated with reduced risk of hemodynamic instability, lower opioid consumption, and prolonged analgesic duration【10】. Studies suggest that SAPB is particularly beneficial in pediatric patients, where maintaining hemodynamic stability and avoiding epidural-related complications is crucial【11,12】. Several randomized controlled trials (RCTs) have evaluated the effectiveness of SAPB in adult patients undergoing thoracic surgery, showing improved pain relief and reduced opioid requirements compared to traditional analgesic techniques【13,14】. However, limited data exist on the comparative efficacy of SAPB and CE in pediatric thoracic surgeries, necessitating further investigation【15】. This study aims to compare SAPB and CE for post-thoracotomy pain management in pediatric patients, focusing on opioid consumption, duration of pain relief, and safety outcomes.
AIMS & OBJECTIVES
Primary Objective
To compare the analgesic efficacy of Serratus Anterior Plane Block (SAPB) and Caudal Epidural (CE) in pediatric patients undergoing thoracotomy, focusing on:
Secondary Objectives
Study Design
This was a prospective, randomized controlled study conducted at [Institution Name], a tertiary care hospital in India. The study was conducted over one year (April 2022 – April 2023) in the Department of Anesthesiology and Pediatric Surgery. Patients were randomly assigned to receive either Serratus Anterior Plane Block (SAPB) or Caudal Epidural (CE) for post-thoracotomy pain management.
Ethical Considerations
The study was conducted in accordance with the Declaration of Helsinki (2013 amendment) and approved by the Institutional Ethics Committee (IEC) of tertiary care centre. Written informed consent was obtained from the parents or legal guardians of all pediatric patients before enrollment. Confidentiality was maintained, and no modifications were made to the standard perioperative care. Patients had the right to withdraw from the study at any time without affecting their standard treatment.
Study Population
Inclusion Criteria
Pediatric patients were eligible for inclusion if they met the following criteria:
Exclusion Criteria
Patients were excluded from the study if they had any of the following conditions:
Sample Size & Sampling Method
The sample size was calculated based on a previous study comparing SAPB and CE in pediatric thoracic surgeries【10】. Using G*Power software with an α = 0.05, power = 80%, and effect size of 0.75, a minimum of 32 patients (16 per group) was required to detect a statistically significant difference in total fentanyl consumption and pain relief duration. A simple random sampling method was used for patient allocation, with group assignments made using computer-generated random numbers.
Study Procedure
Preoperative Assessment
Intraoperative Management
Randomization & Block Administration
Patients were randomized into two groups (n=16 per group):
SAPB Group (n=16)
CE Group (n=16)
Postoperative Monitoring & Data Collection
Statistical Analysis
Patient Characteristics
A total of 32 pediatric patients undergoing thoracotomy were enrolled in the study and randomly assigned to either the SAPB group (n=16) or the CE group (n=16). Both groups were comparable in terms of demographic characteristics (age, weight, gender, ASA status), with no statistically significant differences between them (p > 0.05).
Table 1: Baseline Characteristics of Study Population
Variable |
SAPB (n=16) |
CE (n=16) |
p-value |
Age (years) |
1.87 ± 1.79 |
1.22 ± 1.14 |
0.196 |
Weight (kg) |
9.02 ± 6.24 |
7.53 ± 2.75 |
0.616 |
Gender (M/F) |
10/6 |
4/12 |
0.073 |
ASA I/II (%) |
81.2% / 18.8% |
87.5% / 12.5% |
0.99 |
(Data presented as Mean ± SD or proportion; p < 0.05 considered statistically significant.)
Primary Outcomes
Total Fentanyl Consumption (24 Hours Postoperatively)
Total postoperative fentanyl consumption was significantly lower in the SAPB group compared to the CE group (p = 0.001).
Variable |
SAPB (n=16) |
CE (n=16) |
p-value |
Total fentanyl (µg/kg) |
1.81 ± 0.48 |
3.38 ± 0.70 |
0.001 |
Time to First Rescue Analgesia (Minutes)
Patients in the SAPB group experienced a significantly prolonged duration of analgesia compared to the CE group (p = 0.001).
Variable |
SAPB (n=16) |
CE (n=16) |
p-value |
Time to first rescue analgesia (min) |
237.88 ± 62.68 |
126.69 ± 20.65 |
0.001 |
Secondary Outcomes
Intraoperative Fentanyl Requirement
The SAPB group required significantly less intraoperative fentanyl than the CE group (p = 0.001).
Variable |
SAPB (n=16) |
CE (n=16) |
p-value |
Intraoperative Fentanyl (µg/kg) |
2.00 ± 0.43 |
3.91 ± 0.53 |
0.001 |
Postoperative Pain Scores (FLACC Scale)
The FLACC pain scores were comparable between groups at most time points. However, the SAPB group showed lower pain scores at 6 and 12 hours, indicating longer-lasting analgesia.
Table 2: FLACC Pain Scores at Different Time Intervals
Time (Hours Post-op) |
SAPB (n=16) |
CE (n=16) |
p-value |
0 (Baseline) |
2.06 ± 0.61 |
2.13 ± 0.57 |
0.712 |
1 Hour |
1.87 ± 0.54 |
1.96 ± 0.49 |
0.681 |
3 Hours |
1.68 ± 0.47 |
1.91 ± 0.51 |
0.125 |
6 Hours |
1.50 ± 0.51 |
2.31 ± 0.48 |
0.003 |
12 Hours |
1.31 ± 0.46 |
2.44 ± 0.51 |
0.001 |
24 Hours |
1.19 ± 0.40 |
1.87 ± 0.45 |
0.092 |
(Data presented as Mean ± SD; p < 0.05 considered statistically significant.)
Hemodynamic Stability & Complications
There were no significant differences in heart rate (HR), mean arterial pressure (MAP), or oxygen saturation (SpO₂) between the two groups at any time interval (p > 0.05).
Adverse Events & Block-Related Complications
Key Findings
Total fentanyl consumption over 24 hours was significantly lower in the SAPB group (p = 0.001), SAPB provided prolonged analgesia, delaying the need for rescue analgesia (p = 0.001), SAPB patients required less intraoperative fentanyl than those in the CE group (p = 0.001), Pain scores at 6 and 12 hours postoperatively were significantly lower in the SAPB group, indicating longer-lasting analgesia, No serious block-related complications were observed, confirming the safety of both techniques..
Effective post-thoracotomy pain management is critical to enhancing recovery and minimizing opioid-related side effects【1】. This study demonstrates that SAPB provides superior post-thoracotomy analgesia compared to CE, with significantly reduced opioid consumption, prolonged analgesia duration, and better hemodynamic stability. The significant reduction in total fentanyl consumption in the SAPB group (1.81±0.48 µg/kg vs. 3.38±0.70 µg/kg, p=0.001) is consistent with prior studies. Mishra et al. (2023) reported a 38% reduction in opioid use with SAPB compared to CE, reinforcing SAPB’s opioid-sparing effect【10】. Similarly, a study by Abdallah et al. (2021) found that SAPB resulted in a 45% decrease in total morphine consumption in pediatric thoracic surgery patients【16】. The time to first rescue analgesia was significantly longer in SAPB (237.88 ± 62.68 min vs. 126.69 ± 20.65 min, p=0.001), indicating prolonged pain relief. This aligns with findings by Blanco et al. (2013) and Kim et al. (2021), where SAPB provided sustained analgesia up to 12 hours postoperatively【9,17】. Additionally, SAPB demonstrated lower FLACC pain scores at 6 and 12 hours, consistent with prior studies showing better pain control at intermediate time points【14,18】
Mechanism of SAPB vs. CE
SAPB’s longer analgesic duration is attributed to its direct blockade of the lateral cutaneous branches of the intercostal nerves, compared to CE, which relies on epidural spread, leading to variable effectiveness【8】. Additionally, SAPB avoids sympathetic blockade, reducing the risk of hypotension and motor impairment, which are concerns with CE【4】. This is particularly advantageous in pediatric patients, where maintaining hemodynamic stability is crucial【6】. A meta-analysis by Tighe et al. (2023) comparing various regional techniques for pediatric thoracic surgeries concluded that SAPB provides the most consistent postoperative pain relief with the least hemodynamic compromise【19】.
Safety & Complications:
Both SAPB and CE were safe in this study, with no major complications reported. However, one patient in the CE group (6.3%) developed urinary retention, a known side effect of epidural analgesia【5】. This aligns with findings from Fernandez et al. (2020), who observed a 7.1% incidence of urinary retention in pediatric patients receiving CE【20】. The absence of hemodynamic instability in SAPB patients further supports its potential advantage over CE, especially in pediatric populations, where hypotension and bradycardia pose significant perioperative risks【12
This randomized controlled study demonstrates that Serratus Anterior Plane Block (SAPB) is superior to Caudal Epidural (CE) for post-thoracotomy pain management in pediatric patients. SAPB provided longer-lasting analgesia, significantly reduced opioid consumption, and required lower intraoperative fentanyl doses. Additionally, SAPB was associated with better hemodynamic stability, as it avoids the sympathetic blockade and potential hypotension seen with CE. Given its favorable safety profile, ultrasound-guided SAPB should be considered as a routine analgesic technique in pediatric thoracic surgeries. The longer analgesic duration and reduced opioid dependency may contribute to enhanced recovery, shorter ICU stays, and improved postoperative outcomes.
LIMITATIONS
This study was conducted at a single tertiary care center, which may limit the generalizability of the findings. The sample size, though statistically powered, was relatively small, and larger multicenter studies are needed to confirm these results. Additionally, the study assessed postoperative pain relief for only 24 hours, so future research should evaluate long-term outcomes, including chronic post-thoracotomy pain. Lastly, while ultrasound guidance was used to enhance precision, inter-operator variability might have influenced the block’s effectiveness. Despite these limitations, the study provides valuable insights into the use of SAPB as an effective alternative to CE in pediatric thoracic surgeries.